New procedure helps patients with severe asthma breathe easier
Northwestern Memorial offers first non-drug, FDA approved therapy for severe asthma.
Northwestern Memorial offers first non-drug, FDA approved therapy for severe asthma.
Older patients with chronic obstructive pulmonary disease (COPD) are at increased risk for carotid artery plaque formation and for the presence of vulnerable plaques with a lipid core,… read more.
Asthma is more common among children born after infertility treatment than among children who have been planned and conceived naturally, according to findings from the UK Millennium Cohort… read more.
A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University.
According to a new study from the Slone Epidemiology Center (SEC) at Boston University, African-American women who reported suffering abuse before age 11 had a greater likelihood of… read more.
New research shows that one in seven or 15% of Irish people have an undiagnosed lung condition and that this figure doubles to almost 30% in people over… read more.
by Dr Aidan O’Brien, Consultant Respiratory Physician, Mid Western Regional Hospital, Limerick, Local Organiser of the ITS Meeting 2012 – State of the art developments in respiratory medicine… read more.
Nonsteroidal anti-inflammatory drugs, especially aspirin, may help prevent serious liver problems, a large observational study suggested.
Nonsteroidal anti-inflammatory drugs, especially aspirin, may help prevent serious liver problems, a large observational study suggested.
While scientific evidence suggests that less is typically more when it comes to diagnosing and treating low-back pain in the US, the number of expensive imaging exams and… read more.
A new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC –… read more.
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.